Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Chiappori

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 29, 2010
Features of potentially predictive biomarkers of chemotherapeutic efficacy in small cell lung cancerAlberto A Chiappori, Zhong Zheng, Tingan Chen, et al.
BMJ Open|September 15, 2016
Longitudinal cohort study to determine effectiveness of a novel simulated case and feedback system to improve clinical pathway adherence in breast, lung and GI cancersTimothy Kubal, Doug G Letson, Alberto A Chiappori, et al.
Pulmonary Pharmacology & Therapeutics|July 7, 2012
COPD treatment: real life and experimental effects on peripheral NK cells, their receptors expression and their IFN-γ secretionC Folli, A Chiappori, M Pellegrini, et al.
International Journal of Immunopathology and Pharmacology|June 16, 2012
Omalizumab modulates bronchial reticular basement membrane thickness and eosinophil infiltration in severe persistent allergic asthma patientsA M Riccio, R W Dal Negro, C Micheletto, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 23, 2008
Cardiac toxicity: old and new issues in anti-cancer drugsM Sereno, A Brunello, A Chiappori, et al.
British Journal of Cancer|March 19, 2019
Phase 1 trial of dasatinib combined with afatinib for epidermal growth factor receptor- (EGFR-) mutated lung cancer with acquired tyrosine kinase inhibitor (TKI) resistanceBen C Creelan, Jhanelle E Gray, Tawee Tanvetyanon, et al.
Minerva Chirurgica|June 1, 1995
[Adhesive peritonitis caused by a foreign body. A case report]E Brignole, T Testa, E Squillario, et al.
International Journal of Immunopathology and Pharmacology|June 16, 2012
Salbutamol: how does it enter smooth muscle cells?A Chiappori, C Folli, A M Riccio, et al.
Oncology (Williston Park, N.Y.)|December 19, 2015
Propelling Immunotherapy Combinations Into the ClinicNishan Tchekmedyian, Jhanelle E Gray, Benjamin C Creelan, et al.
Clinical Nuclear Medicine|January 29, 2013
Variance of SUVs for FDG-PET/CT is greater in clinical practice than under ideal study settingsVirendra Kumar, Kavindra Nath, Claudia G Berman, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 29, 2010
Features of potentially predictive biomarkers of chemotherapeutic efficacy in small cell lung cancerAlberto A Chiappori, Zhong Zheng, Tingan Chen, et al.
BMJ Open|September 15, 2016
Longitudinal cohort study to determine effectiveness of a novel simulated case and feedback system to improve clinical pathway adherence in breast, lung and GI cancersTimothy Kubal, Doug G Letson, Alberto A Chiappori, et al.
Pulmonary Pharmacology & Therapeutics|July 7, 2012
COPD treatment: real life and experimental effects on peripheral NK cells, their receptors expression and their IFN-γ secretionC Folli, A Chiappori, M Pellegrini, et al.
International Journal of Immunopathology and Pharmacology|June 16, 2012
Omalizumab modulates bronchial reticular basement membrane thickness and eosinophil infiltration in severe persistent allergic asthma patientsA M Riccio, R W Dal Negro, C Micheletto, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 23, 2008
Cardiac toxicity: old and new issues in anti-cancer drugsM Sereno, A Brunello, A Chiappori, et al.
British Journal of Cancer|March 19, 2019
Phase 1 trial of dasatinib combined with afatinib for epidermal growth factor receptor- (EGFR-) mutated lung cancer with acquired tyrosine kinase inhibitor (TKI) resistanceBen C Creelan, Jhanelle E Gray, Tawee Tanvetyanon, et al.
Minerva Chirurgica|June 1, 1995
[Adhesive peritonitis caused by a foreign body. A case report]E Brignole, T Testa, E Squillario, et al.
International Journal of Immunopathology and Pharmacology|June 16, 2012
Salbutamol: how does it enter smooth muscle cells?A Chiappori, C Folli, A M Riccio, et al.
Oncology (Williston Park, N.Y.)|December 19, 2015
Propelling Immunotherapy Combinations Into the ClinicNishan Tchekmedyian, Jhanelle E Gray, Benjamin C Creelan, et al.
Clinical Nuclear Medicine|January 29, 2013
Variance of SUVs for FDG-PET/CT is greater in clinical practice than under ideal study settingsVirendra Kumar, Kavindra Nath, Claudia G Berman, et al.
Pageof 6